Compare Lumen Technologies Inc (LUMN) vs Koninklijke Philips NV (PHG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Lumen Technologies Inc vs Koninklijke Philips NV — how do they compare? Lumen Technologies Inc trades at $5.28 (market cap $5.73B), while Koninklijke Philips NV trades at $24.24 (market cap $23.52B). The key difference: Koninklijke Philips NV is far larger — about 4.1× Lumen Technologies Inc's market cap, and Koninklijke Philips NV pays a 4.17% dividend while Lumen Technologies Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Lumen Technologies Inc for 40 Days and Koninklijke Philips NV for 84 Days on average.
| LUMN | PHG | |
|---|---|---|
Market Cap | $5.73B | $23.52B |
Volume | 17,079,799 | 1,635,069 |
Sector | Media | Health |
52-Week High | $11.83 | $32.91 |
52-Week Low | $5.28 | $23.81 |
Typical Hold Time | 40 Days | 84 Days |
Enterprise Value | $17.35B | $29.87B |
Dividend Yield | — | 4.17% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Lumen Technologies (LUMN) trades at $5.56, down 5.92% with bearish technical signals. The company reported mixed Q2 2026 results, beating EPS estimates but showing negative profitability metrics. Recent strategic moves include transferring to Nasdaq and launching Intelligent Internet services targeting AI-driven enterprise networking. Revenue declined to $12.4B in 2025 with a net loss of $1.74B, though operating cash flow remains strong at $4.74B. Analyst sentiment is cautious with 61% hold ratings.
LUMN presents a high-risk turnaround opportunity with potential from AI networking growth but faces significant challenges including $17.49B debt load, declining legacy revenue, and negative ROE. The stock's deep value (P/S 0.47) attracts speculative interest, but execution risks and competitive pressures warrant caution. Near-term catalysts include Q3 earnings and Nasdaq listing transition.
PHG trades at $24.30, up 0.87% with a bearish technical signal despite recent earnings beats. The company shows improving fundamentals with net income turning positive to $895M in 2025 after previous losses, supported by strong cash flow generation. Recent news highlights product innovations including new CT systems and AI healthcare advancements, while institutional ownership shows mixed activity.
The outlook remains cautious with analyst consensus at Hold (63.64%) despite positive earnings momentum. Key risks include cybersecurity threats and competitive pressures in health technology. The stock presents a recovery opportunity but requires monitoring of execution risks and market sentiment shifts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Lumen Technologies Inc
With 450,000 route miles of fiber, including over 35,000 route miles of subsea fiber connecting Europe, Asia, and Latin America, Lumen Technologies is one of the United States' largest telecommunications carriers serving global enterprises. Its merger with Level 3 further shifted the company's operations toward businesses (over 70% of revenue) and away from its legacy consumer business. Lumen offers businesses a full menu of communications services, providing colocation and data center services, data transportation, and end-user phone and internet service. On the consumer side, Lumen provides broadband and phone service across 37 states, where it has 4.5 million broadband customers.
Read more on LUMN →About Koninklijke Philips NV
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →
